PT90310A - Processo para a obtencao de preparacoes de adenilato-ciclase - Google Patents

Processo para a obtencao de preparacoes de adenilato-ciclase

Info

Publication number
PT90310A
PT90310A PT90310A PT9031089A PT90310A PT 90310 A PT90310 A PT 90310A PT 90310 A PT90310 A PT 90310A PT 9031089 A PT9031089 A PT 9031089A PT 90310 A PT90310 A PT 90310A
Authority
PT
Portugal
Prior art keywords
adenylate cyclase
preparation
adenilate
obtaining
calmodulin
Prior art date
Application number
PT90310A
Other languages
English (en)
Other versions
PT90310B (pt
Inventor
Jean-Michel Alonso
Colette Brezin
Jean-Luc Boucaud
Murielle Rocancourt
Marek Szatanik
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of PT90310A publication Critical patent/PT90310A/pt
Publication of PT90310B publication Critical patent/PT90310B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT90310A 1988-04-19 1989-04-19 Processo para a obtencao de preparacoes de adenilato-ciclase PT90310B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400949A EP0338169B1 (en) 1988-04-19 1988-04-19 Method for obtaining protective antigens against bordetella infections and toxic processes

Publications (2)

Publication Number Publication Date
PT90310A true PT90310A (pt) 1989-11-10
PT90310B PT90310B (pt) 1994-09-30

Family

ID=8200381

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90310A PT90310B (pt) 1988-04-19 1989-04-19 Processo para a obtencao de preparacoes de adenilato-ciclase

Country Status (10)

Country Link
US (1) US5595901A (pt)
EP (2) EP0691348A1 (pt)
JP (1) JP2999480B2 (pt)
AT (1) ATE140729T1 (pt)
CA (1) CA1341332C (pt)
DE (1) DE3855442T2 (pt)
DK (1) DK175663B1 (pt)
ES (1) ES2091186T3 (pt)
GR (1) GR3021331T3 (pt)
PT (1) PT90310B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2736064B1 (fr) 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
WO1999057120A1 (en) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001271908A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2606789B1 (fr) * 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0338170A1 (en) * 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
US5312749A (en) * 1992-05-12 1994-05-17 The United States Of America As Represented By The Secretary Of Agriculture Industrial alkaline protease from shipworm bacterium

Also Published As

Publication number Publication date
DK175663B1 (da) 2005-01-10
US5595901A (en) 1997-01-21
ATE140729T1 (de) 1996-08-15
CA1341332C (en) 2002-01-08
DE3855442T2 (de) 1997-03-06
JP2999480B2 (ja) 2000-01-17
EP0691348A1 (en) 1996-01-10
ES2091186T3 (es) 1996-11-01
GR3021331T3 (en) 1997-01-31
DE3855442D1 (de) 1996-08-29
DK190989D0 (da) 1989-04-19
EP0338169A1 (en) 1989-10-25
DK190989A (da) 1989-10-20
PT90310B (pt) 1994-09-30
JPH02131432A (ja) 1990-05-21
EP0338169B1 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
PT90310A (pt) Processo para a obtencao de preparacoes de adenilato-ciclase
WO1990014067A3 (en) Methods for treating anxiety with sigma receptor ligands
NO20003716L (no) Protein D for anvendelse in vitro, renset antistoff som binder proteinet, samt anvendelser derav
BR9102832A (pt) Produto absorvente e metodo de fixar o mesmo
ES2102009T5 (es) Tratamiento para el asma.
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
ATE61937T1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
AU561016B2 (en) N-glycosylated carboxamide derivatives
KR900700132A (ko) 면역 글로불린 e 반응 억제 방법
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
ES2070820T3 (es) Anticuerpos monoclonales especificos de la apolipoproteina b, producidos por dos nuevos hibridomas.
DK455088D0 (da) Syntetiske receptoranaloger
YU48525B (sh) Protein, dnk koji kodira protein, rekombinantni vektor koji obuhvata dnk i postupak za proizovodnju proteina
ATE120209T1 (de) Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.
EP0331327A3 (en) Agent for blocking nonspecific adsorption, process for preparing thereof and method of blocking nonspecific adsorption
SE9300139D0 (sv) Manufacture of a new drug
DE69015314D1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
Charlot et al. C 273 and DA 193 Mapped with Crustal Dynamics VLBI Data
Ishaq et al. Purification and identification of antigenic polypeptides of Sm and RNP antigens of goat liver
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
Cesura et al. Affinity chromatography of human platelet monoamine oxidase-B
SE8603050D0 (sv) Reagenssats och dess anvendnilng for att bilda (hpasp - anti-hpasp)-immunkomplex, samt diagnostiskt forfarande vid vilet hpasp detekteras

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940317